Boston Pharmaceuticals Presents Data at NASH-TAG 2024 Demonstrating Low Immunogenicity Over Time With Long-acting FGF21 Analogue, BOS-580, for MASH
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan 5, 2024--
Source: eagletribune.com
📰 Immunogenicity Reported News
Immunogenicity Reported News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Immunogenicity Reported. Real-time updates on events, politics, business and more.